Bell Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $5.75M | Sell |
|
|||||
|
2024
Q2 | $9.26M | Buy |
|
|||||
|
2024
Q1 | $10.5M | Sell |
|
|||||
|
2023
Q4 | $10.3M | Sell |
|
|||||
|
2023
Q3 | $9.86M | Buy |
|
|||||
|
2023
Q2 | $9.65M | Buy |
|
|||||
|
2023
Q1 | $8.4M | Sell |
|
|||||
|
2022
Q4 | $9.12M | Sell |
|
|||||
|
2022
Q3 | $8.31M | Buy |
|
|||||
|
2022
Q2 | $8.48M | Buy |
|
|||||
|
2022
Q1 | $8.89M | Buy |
|
|||||
|
2021
Q4 | $9.2M | Buy |
|
|||||
|
2021
Q3 | $6.78M | Sell |
|
|||||
|
2021
Q2 | $6.4M | Sell |
|
|||||
|
2021
Q1 | $5.04M | Sell |
|
|||||
|
2020
Q4 | $5.36M | Buy |
|
|||||
|
2020
Q3 | $4.6M | Sell |
|
|||||
|
2020
Q2 | $4.29M | Sell |
|
|||||
|
2020
Q1 | $5.28M | Buy |
|
|||||
|
2019
Q4 | $5.05M | Buy |
|